日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In Pursuit of Person-Centered Medicine: How Do People with Type 2 Diabetes Choose Glucose-Lowering Medications? A Qualitative Study

追求以人为本的医疗:2型糖尿病患者如何选择降血糖药物?一项定性研究

Golembiewski, Elizabeth H; Ning, Xinyuan; Mickelson, Mindy M; Gockerman, Janet P; Tesulov, Michael; Labatte, Bertina; McCoy, Rozalina G

First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity

Minnelide 对晚期胃肠道癌症患者进行的首次人体 I 期研究:安全性、药代动力学、药效学和抗肿瘤活性

Erkut Borazanci, Ashok Saluja, Jon Gockerman, Mohana Velagapudi, Ronald Korn, Daniel Von Hoff, Ed Greeno

Diabetic Kidney Disease Prevention Care Model Development

糖尿病肾病预防护理模式的开发

ElSayed, Nuha A; Bannuru, Raveendhara R; Bakris, George; Bardsley, Joan; de Boer, Ian H; Gabbay, Robert A; Gockerman, Janet; McCoy, Rozalina G; McCracken, Elaine; Neumiller, Joshua J; Pilla, Scott J; Rhee, Connie M

Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study

患者在选择降血糖药物时重视的疗效和特性:一项混合方法研究

Golembiewski, Elizabeth H; Garcia Bautista, Andrea E; Polley, Eric; Umpierrez, Guillermo E; Galindo, Rodolfo J; Brito, Juan P; Montori, Victor M; Gockerman, Janet P; Tesulov, Michael; Labatte, Bertina; Mickelson, Mindy M; McCoy, Rozalina G

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

慢性淋巴细胞白血病和调节性B细胞都具有IL-10活性和免疫抑制功能。

DiLillo, D J; Weinberg, J B; Yoshizaki, A; Horikawa, M; Bryant, J M; Iwata, Y; Matsushita, T; Matta, K M; Chen, Y; Venturi, G M; Russo, G; Gockerman, J P; Moore, J O; Diehl, L F; Volkheimer, A D; Friedman, D R; Lanasa, M C; Hall, R P; Tedder, T F

A phase I study of ABT-510 plus bevacizumab in advanced solid tumors

ABT-510 联合贝伐单抗治疗晚期实体肿瘤的 I 期研究

Hope E Uronis, Stephanie M Cushman, Johanna C Bendell, Gerard C Blobe, Michael A Morse, Andrew B Nixon, Andrew Dellinger, Mark D Starr, Haiyan Li, Kellen Meadows, Jon Gockerman, Herbert Pang, Herbert I Hurwitz

Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma

一项针对难治性或复发性弥漫性大B细胞淋巴瘤成年患者的II期开放标签研究,评估口服血管内皮生长因子受体抑制剂PTK787/ZK222584(vatalanib)的疗效。

Brander, Danielle; Rizzieri, David; Gockerman, Jon; Diehl, Louis; Shea, Thomas Charles; Decastro, Carlos; Moore, Joseph O; Beaven, Anne

Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia

急性髓系白血病患者根据第14天骨髓活检结果决定再诱导治疗方案

Morris, Tod A; DeCastro, Carlos M; Diehl, Louis F; Gockerman, Jon P; Lagoo, Anand S; Li, Zhiguo; Moore, Joseph O; Rizzieri, David A; Rao, Arati V

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

贝伐单抗、依维莫司和帕尼单抗治疗晚期实体瘤的I期研究

Vlahovic, Gordana; Meadows, Kellen L; Uronis, Hope E; Morse, Michael A; Blobe, Gerard C; Riedel, Richard F; Zafar, S Yousuf; Alvarez-Secord, Angeles; Gockerman, Jon; Starodub, Alexander N; Ready, Neal E; Anderson, Elizabeth L; Bendell, Johanna C; Hurwitz, Herbert I

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

在滤泡性淋巴瘤患者首次缓解期接种患者特异性肿瘤衍生抗原疫苗可提高无病生存期。

Schuster, Stephen J; Neelapu, Sattva S; Gause, Barry L; Janik, John E; Muggia, Franco M; Gockerman, Jon P; Winter, Jane N; Flowers, Christopher R; Nikcevich, Daniel A; Sotomayor, Eduardo M; McGaughey, Dean S; Jaffe, Elaine S; Chong, Elise A; Reynolds, Craig W; Berry, Donald A; Santos, Carlos F; Popa, Mihaela A; McCord, Amy M; Kwak, Larry W